AscellaHealth Supports Bleeding Disorders Awareness Month, Provides High-Touch Specialty Pharmacy Solutions, Improves Outcomes, Lowers Costs

March 26, 2019
March is time to raise awareness for rare bleeding disorders and take part in advocacy activities, including social media campaigns

AnchorAnchor Berwyn, PA – March 2019 – In recognition of March as Bleeding Disorders Awareness Month , AscellaHealth (Ascella), a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, urges patients, families and communities to show support for individuals living with bleeding disorders, including hemophilia, von Willebrand disease, and rare factor deficiencies. To help overcome the complexity and collaboration required in the management of bleeding disorders, Ascella’s Clinical and Educational Programs educate members on their prescribed therapy beginning day one, assisting with high deductible/co-insurance costs by utilizing financial assistance programs and partnering with physicians and pharmacist throughout the member’s course of treatment.

“By partnering with health plans, employer groups and unions, Ascella improves outcomes and care coordination for members with bleeding disorders,” says Dea Belazi, president and CEO, AscellaHealth, says, “Our high-touch model includes clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination as part of Ascella’s innovative specialty pharmacy strategy.”

Ascella’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting

The average annual cost of clotting factor products can range from $50,000 to $100,000 dollars, while complications such as inhibitors, orthopedic surgery, hepatitis, and HIV disease can raise costs even higher.

“Ascella also provides discounted pricing as part of the considerable value we create, especially in specialty drug pricing,” Belazi adds. “This March we are more committed than ever to making a difference for plan members by creating custom benefit designs, maximizing benefit plans and reducing costs.”

About AscellaHealth
AscellaHealth, a national PBM serving commercial, Medicare and Medicaid segments offers high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs through its unique and proprietary service that extends discounts on prescription medications to customers more than any other PBM in the industry. Visit www.ascellahealth.com .